Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis
Lanas, A., Wu, P., Medin, J. & Mills, E. J. Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin. Gastroenterol. Hepatol. 9, 762-768 (2011).
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
Bhatt, D. L. et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J. Am. Coll. Cardiol. 52, 1502-1517 (2008).
Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: Data from a prospective multicenter capsule endoscopy registry
Endo, H. et al. Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: data from a prospective multicenter capsule endoscopy registry. Gastrointest. Endosc. http://dx.doi.org/10.1016/j.gie.2014.03.024.
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis
Wallace, J. L. et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 141, 1314-1322 (2011).
Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials
Antithrombotic Trialists' (ATT) Collaboration
Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373, 1849-1860 (2009).
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product
Kelly, J. P. et al. Risk of aspirin-associated major upper- gastrointestinal bleeding with enteric-coated or buffered product. Lancet 348, 1413-1416 (1996).
Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: Long-term follow-up of a cohort of patients commonly using PPI co-therapy
Casado Arroyo, R. et al. Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy. Heart 98, 718-723 (2012).
Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in Japan
Miyamoto, M. et al. Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in Japan. J. Gastroenterol. Hepatol. 27, 372-377 (2012).
A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal anti-inflammatory drug use
Lanas, A. et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal anti-inflammatory drug use. Am. J. Gastroenterol. 100, 1685-1693 (2005).
